NCT05433064 Spinal Cord Stimulation for Spinal Cord Injury Patients - Regain Walk and Alleviate Pain
| NCT ID | NCT05433064 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Buddhist Tzu Chi General Hospital |
| Condition | Spinal Cord Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2020-05-01 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2020-05-01 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to examine the plausible interventional mechanisms underlying the effects of epidural spinal cord stimulation.
Eligibility Criteria
Inclusion Criteria: * SCI ASIA: A, B, C,D * Between 20 and 70 year of age * \>1 year post SCI * Complete or incomplete spinal cord injury. * Expected will undergo spinal cord stimulation surgery. * Continued rehabilitation after surgery for spinal cord injury. * Able to comply with procedures and follow up. * Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate participation in lower extremity rehabilitation or testing activities Exclusion Criteria: * Have significant cognitive impairment (MMSE\<24). * Had a mental illness within one year or been treated in the past. * Have Major depressive disorder. * Active cancer diagnosis. * Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection that might interfere with stand or step training. * Cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention. * Unable to read and/or comprehend the consent form. * Have concerns about this trial and do not sign consent.
Contact & Investigator
Sheng-Tzung Tsai, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Hualien Tzu Chi General Hospital
Frequently Asked Questions
Who can join the NCT05433064 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05433064 currently recruiting?
Yes, NCT05433064 is actively recruiting participants. Contact the research team at flydream.tsai@gmail.com for enrollment information.
Where is the NCT05433064 trial being conducted?
This trial is being conducted at Hualien City, Taiwan.
Who is sponsoring the NCT05433064 clinical trial?
NCT05433064 is sponsored by Buddhist Tzu Chi General Hospital. The principal investigator is Sheng-Tzung Tsai, M.D., Ph.D. at Hualien Tzu Chi General Hospital. The trial plans to enroll 12 participants.